Task: Answer the following question about the molecule with SMILES CCCC(C(=O)c1ccc(C)cc1)N1CCCC1.Cl.
Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Completion: Approved
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CCCC(C(=O)c1ccc(C)cc1)N1CCCC1.Cl
CCCC(C(=O)c1ccc(C)cc1)N1CCCC1.Cl
1-(4-methylphenyl)-2-pyrrolidin-1-ylpentan-1-one;hydrochloride
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.